Tolazamide

  • TRADE NAMES: Diabewas; Diadutos; Norglycin; Tolanase; Tolinase (Pfizer); Tolisan
  • INDICATIONS: Non-insulin dependent diabetes Type II
  • CLASS: Sulfonylurea
  • HALF-LIFE: 7 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Phenylbutazones

PREGNANCY CATEGORY: C

Tolazamide is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.

Our database has 11 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
GASTROINTESTINAL/HEPATIC


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric